What we are studying
The purpose of this study is to evaluate the effect and safety of different doses of ABT-494 and to assess how drug is absorbed, distributed, and eliminated in the body over time of ABT-494 in subjects with moderate to severe Crohn's Disease. Some subjects will receive ABT-494 and some subjects will receive placebo. This means you could receive inactive drug.
50.00 per visit. Paid by check at end of study or early withdrawal.